A detailed history of Catalina Capital Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Catalina Capital Group, LLC holds 3,630 shares of NVO stock, worth $381,367. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,630
Previous 3,631 0.03%
Holding current value
$381,367
Previous $518 Million 16.61%
% of portfolio
0.14%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$119.07 - $145.42 $119 - $145
-1 Reduced 0.03%
3,630 $432 Million
Q2 2024

Jul 24, 2024

BUY
$122.71 - $146.91 $2,331 - $2,791
19 Added 0.53%
3,631 $518 Million
Q1 2024

May 03, 2024

BUY
$102.11 - $135.92 $368,821 - $490,943
3,612 New
3,612 $464 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Catalina Capital Group, LLC Portfolio

Follow Catalina Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalina Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalina Capital Group, LLC with notifications on news.